Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Industry Involvement In Guidance Development Encouraged By FDA Working Group

This article was originally published in The Gray Sheet

Executive Summary

In a report on best practices for guidance development, FDA encourages outside groups to submit their own draft guidance proposals to help make the overall process more efficient.

Advertisement

Related Content

Is Draft Guidance More Than Meets The Eye? Senators Seek Answers From FDA
FDA’s Regulatory Rock And Hard Place: How To Handle Draft Guidances
Draft Guidance More Than Meets The Eye? Senators Seek Answers From FDA
Is Draft Guidance More Than Meets The Eye? Senators Seek Answers From FDA
FDA Wants To Release “Masked” Marketing Application Data To Researchers
FDA Unveils Plan To Boost Transparency To Industry
FDA Unveils 21 Policy Changes To Increase Transparency With Public

Topics

Advertisement
UsernamePublicRestriction

Register

MT030862

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel